Submission Details
| 510(k) Number | K002738 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | September 01, 2000 |
| Decision Date | December 19, 2000 |
| Days to Decision | 109 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | Summary PDF |
K002738 is an FDA 510(k) clearance for the BAYER RAPIDPOINT 400 SYSTEM, a Electrode Measurement, Blood-gases (pco2, Po2) And Blood Ph (Class II — Special Controls, product code CHL), submitted by Bayer Corp. (Medfield, US). The FDA issued a Cleared decision on December 19, 2000, 109 days after receiving the submission on September 1, 2000. This device falls under the Chemistry review panel. Regulated under 21 CFR 862.1120.
| 510(k) Number | K002738 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | September 01, 2000 |
| Decision Date | December 19, 2000 |
| Days to Decision | 109 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | Summary PDF |
| Product Code | CHL — Electrode Measurement, Blood-gases (pco2, Po2) And Blood Ph |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 862.1120 |